Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DMBT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANOS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKLE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC285847 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NCAPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPATCH2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFT52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GCFC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEPROT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928327 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLIN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on